Armando Zuniga PhD

Dr. Zuniga joined Virometix as CSO in July 2013. He previously worked at Crucell/Berna Biotech Ltd., where he held senior positions in the recombinant vaccines department and at Redbiotec AG as Head of Pre-Clinical Development. He has 20 years of research experience in Life Sciences and more than 12 years of industry experience in vaccine development. Dr. Zuniga holds a DVM degree from the Institute of Veterinary Bacteriology of the University of Zurich.